INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹128 Cr | ₹94 Cr | ₹68 Cr | ₹64 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of INNOVA CAPTAB ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹128 Cr |
| Mar2025 | ₹94 Cr |
| Mar2024 | ₹68 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹34 Cr |
How is Consolidated Net Profit of INNOVA CAPTAB Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹128 Cr | 35.95 | |
| Mar2025 | ₹94 Cr | 38.84 | |
| Mar2024 | ₹68 Cr | 6.54 | |
| Mar2023 | ₹64 Cr | 85.30 | |
| Mar2022 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹7,332.5 Cr | 7.1% | 24.2% | 50.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 7.1% |
24.2% |
50.2% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses